STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [8-K] Alignment Healthcare, Inc. Reports Material Event

Shareholders at Alignment Healthcare (NASDAQ: ALHC) back directors, auditor and pay

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Alignment Healthcare, Inc. reported the results of its virtual annual stockholder meeting held on June 4, 2026. Stockholders representing 194,112,992 shares of common stock were present or represented by proxy.

All three Class II director nominees — Jody Bilney, David Hodgson, and Jacqueline Kosecoff — were elected to three-year terms ending at the 2029 annual meeting. Stockholders also ratified the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, on an advisory basis, stockholders approved the compensation of the company’s named executive officers in the say-on-pay vote.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Shares represented at meeting 194,112,992 shares Common stock represented at June 4, 2026 annual meeting
Jody Bilney director votes for 135,714,231 votes Election as Class II director at annual meeting
David Hodgson director votes for 108,386,550 votes Election as Class II director at annual meeting
Jacqueline Kosecoff director votes for 135,613,817 votes Election as Class II director at annual meeting
Auditor ratification votes for 194,030,577 votes Ratification of Deloitte & Touche LLP for 2026
Say-on-pay votes for 169,068,300 votes Advisory approval of executive compensation
broker non-vote financial
"Class I Director Name | For | Withhold | Broker Non-Vote"
say-on-pay vote financial
"Proposal 3: Say-on-Pay Vote. On an advisory basis, the executive compensation"
A say-on-pay vote is a shareholder advisory vote on a company’s executive compensation package, usually held at the annual meeting to approve or voice disapproval of how top managers are paid. Think of it as a feedback button for owners: while the vote is often nonbinding, a strong negative outcome warns of governance problems, can force pay-policy changes, damage board credibility and ultimately influence long-term shareholder returns.
independent registered public accounting firm financial
"the independent registered public accounting firm for the Company for the fiscal year ending"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
emerging growth company regulatory
"Emerging growth company o o Item 5.07."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
0001832466FALSE00018324662026-06-042026-06-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 4, 2026
_______________________________
ALIGNMENT HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
_______________________________
Delaware001-4029546-5596242
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
1100 W. Town and Country Road, Suite 1600
Orange, California 92868
(Address of Principal Executive Offices) (Zip Code)
(844) 310-2247
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareALHCThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 5.07. Submission of Matters to a Vote of Security Holders.

The regular annual meeting of the stockholders (the "Annual Meeting") of Alignment Healthcare, Inc. (the "Company") was held virtually on June 4, 2026, for the purpose of voting on the proposals described below. There were 194,112,992 shares of common stock represented at the Annual Meeting. The stockholders of the Company voted as follows on the following matters at the Annual Meeting:

Proposal 1: Election of Class II Directors.

The three Class II directors were elected at the Annual Meeting based upon the following votes:

Class I Director Name             For          Withhold   Broker Non-Vote
Jody Bilney135,714,23142,598,20015,800,560
David Hodgson108,386,55069,925,88115,800,560
Jacqueline Kosecoff135,613,81742,698,61415,800,560

Each Class II director will serve a three-year term until the 2029 annual meeting or until his or her successor shall be elected and qualified.

Proposal 2: Ratification of the Appointment of Deloitte & Touche LLP.

The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified based upon the following votes:

ForAgainstAbstain
194,030,57713,89368,522

Proposal 3: Say-on-Pay Vote.

On an advisory basis, the executive compensation of the Company’s named executive officers was approved based on the following votes:

ForAgainstAbstainBroker Non-Vote
169,068,3008,701,941542,19115,800,560




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Alignment Healthcare, Inc.
Date: June 9, 2026By:/s/ Christopher Joyce
Christopher Joyce
Chief Legal & Administrative Officer

Source: View Original Filing on SEC EDGAR

FAQ

What did Alignment Healthcare (ALHC) stockholders vote on at the 2026 annual meeting?

Stockholders voted on electing three Class II directors, ratifying Deloitte & Touche LLP as independent auditor for 2026, and approving an advisory say-on-pay resolution on executive compensation. All three proposals received sufficient support to pass.

How many Alignment Healthcare (ALHC) shares were represented at the 2026 annual meeting?

A total of 194,112,992 shares of Alignment Healthcare common stock were represented at the annual meeting. This figure includes shares present virtually or by proxy and formed the basis for all voting results disclosed.

Were Alignment Healthcare’s Class II director nominees elected at the 2026 meeting?

Yes, all three Class II director nominees were elected. Jody Bilney, David Hodgson, and Jacqueline Kosecoff each received more “for” than “withhold” votes and will serve three-year terms ending at the 2029 annual meeting of stockholders.

Did Alignment Healthcare (ALHC) stockholders approve the company’s auditor for 2026?

Yes. Stockholders ratified Deloitte & Touche LLP as Alignment Healthcare’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 194,030,577 votes for, 13,893 against, and 68,522 abstentions reported.

Was Alignment Healthcare’s say-on-pay proposal approved in 2026?

Yes, the advisory say-on-pay proposal was approved. Executive compensation for the named executive officers received 169,068,300 votes for, 8,701,941 against, and 542,191 abstentions, with 15,800,560 broker non-votes reported on this proposal.

Which exchange lists Alignment Healthcare (ALHC) common stock?

Alignment Healthcare’s common stock, with a par value of $0.001 per share, is listed on The NASDAQ Stock Market LLC. The trading symbol for the company’s common stock on this exchange is ALHC, as stated in the disclosure.

Filing Exhibits & Attachments

3 documents

Other Documents